Miach Orthopaedics Secures $20 Million Funding Boost in Series B Extension
Financing will enable Miach Orthopaedics continued growth of their commercial organization in the U.S., as well as support clinical initiatives like the Bridge Registry to provide important data on real-world patient outcomes.
The Factors Behind Settlement Determination in Car Accident
Car Accident Car accidents can be financially devastating. For those who are injured in a car accident that was not their fault, compensation may be needed to get their finances back on track and cover all of the expenses related to the accident. While this most commonly covers current medical costs and vehicle damages, it […]
Advancing Patient Care: LyGenesis Doses First Patient in Phase 2a Trial
“In a medical first, we have now dosed our first patient in a clinical trial using their own lymph nodes as living bioreactors to regenerate an ectopic organ,” said Dr. Michael Hufford, Co-Founder and CEO of LyGenesis. “This therapy will potentially be a remarkable regenerative medicine milestone by helping patients with ESLD grow new functional ectopic livers in their own body. If our study is successful and we obtain FDA approval, our allogenic cell therapy could enable one donated liver to treat many dozens of ESLD patients, which could help to tilt the current organ supply-demand imbalance in favor of patients.”
The Impact of Men’s Frontal Hairpieces and Wholesale Solutions
Frontal Hairpieces Introduction In the realm of personal grooming, confidence is often intrinsically tied to appearance. For men experiencing hair loss or thinning, the journey to reclaiming confidence can feel daunting. However, with the emergence of men’s frontal hairpieces, coupled with the convenience of wholesale solutions, a transformative shift is underway in the beauty industry. […]
Managing Clinician Burnout Through Ambient Medical Documentation | By: Manny Krakaris, CEO of Augmedix
Did you know clinician burnout remains a significant challenge for health systems and patients alike with over 50% of clinicians reporting feelings of burnout, largely attributed to manual documentation and administrative burdens? Read what Mr. Krakaris has to say.
Advancing Healthcare Energy: Olympus Awarded PROVISTA Contract
This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the POWERSEAL™ sealer/divider, the SONICBEAT™ ultrasonic portfolio and THUNDERBEAT™ hybrid energy portfolio.
Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device
“We’re eager to collaborate with Laborie, pioneers in diagnostic and therapeutic urologic healthcare,” said iO Urology Co-Founder and CEO Britton Garrett. “CarePath bridges the clinic-patient gap, offering a convenient, accessible solution for managing urological conditions in the home.”
Baird Medical Devices Granted New Class III Certificate by China’s NMPA for Ceramic Thyroid Ablation Needle
“The introduction of the Ceramic Thyroid Ablation Needle signifies another breakthrough innovation in the field of microwave ablation and is a testament to our ongoing commitment to innovation and research,” said Ms. Haimei Wu, Founder and CEO of Baird Medical Devices. “We eagerly anticipate the positive impact of this technology by enhancing the patient treatment experiences and saving lives in the years to come.”
The Vital Role of CDMOs in Bringing New Therapies to Market
The relationship between pharmaceutical companies and CDMOs is fundamentally collaborative, fostering an environment of innovation. By partnering with a CDMO, pharmaceutical firms can access a wide array of technologies and expertise that might otherwise be beyond their reach.
Revolutionary T-Cell Analysis Unveiled for Early Cancer Detection at AACR | Reports Serum Detect
Serum Detect is developing diagnostic tests, using standard liquid biopsy samples, that complement and enhance existing screening techniques for early detection of cancer.
Cutting-edge Grant Helps Noze a Canadian Medical Startup Pave the Way in Tuberculosis Fight
Noze states the grant will fund a groundbreaking clinical study aimed at detecting TB in high-burden countries, using the company’s DiagNoze® — a handheld breathalyzer designed for the real-time detection and screening of various medical conditions, including infectious diseases such as TB.
Advancing Patient Care: ZEISS Unleashes Breakthroughs in Ophthalmic Surgery at ASCRS 2024
Building on its ZEISS Medical Ecosystem, several of the new innovations enable seamless data integration and management across the cataract and refractive workflows, creating a new standard for efficient, personalized ophthalmic care.